ArticleFrontiers in oncology2022

Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database.

Maria Antonietta Barbieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.